Clinical Trials
1.7k
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1522 trials with phase data)• Click on a phase to view related trials
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
- First Posted Date
- 2025-11-10
- Last Posted Date
- 2025-11-10
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 240
- Registration Number
- NCT07226232
- Locations
- 🇺🇸
Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States
🇺🇸Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama, United States
🇺🇸VA Portland Health Care System, Portland, OR, Portland, Oregon, United States
Spinal Neurorehabilitation for Veterans With SCI
- Conditions
- Spinal Cord Injuries
- First Posted Date
- 2025-10-29
- Last Posted Date
- 2025-10-29
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 40
- Registration Number
- NCT07222046
- Locations
- 🇺🇸
Providence VA Medical Center, Providence, RI, Providence, Rhode Island, United States
Boosting Exercise Adherence in Knee Osteoarthritis
- Conditions
- Osteoarthritis, Knee
- First Posted Date
- 2025-10-22
- Last Posted Date
- 2025-10-22
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 360
- Registration Number
- NCT07219732
- Locations
- 🇺🇸
Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States
Implementing a Mobile Health Application for Women Veterans With Urinary Incontinence (MyHealtheBladder): Function QUERI 3.0
- Conditions
- Urinary Incontinence
- First Posted Date
- 2025-10-21
- Last Posted Date
- 2025-10-21
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 20
- Registration Number
- NCT07219433
- Locations
- 🇺🇸
Durham VA Medical Center, Durham, NC, Durham, North Carolina, United States
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder
- Conditions
- Alcohol Use Disorder
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-10-20
- Last Posted Date
- 2025-10-20
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 438
- Registration Number
- NCT07218354
- Locations
- 🇺🇸
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia, Pennsylvania, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 336
- Next